Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay

被引:44
作者
Puig, M
Mihalik, K
Yu, MYW
Feinstone, SM
Major, ME
机构
[1] US FDA, Ctr Biol Evaluat & Res, Lab Hepatitis Viruses, Div Viral Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Lab Plasma Derivat, Div Hematol, Bethesda, MD 20892 USA
关键词
HCV; TaqMan RT-PCR; quantitation; chimpanzee;
D O I
10.1016/S0166-0934(02)00119-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The availability of molecular protocols for the detection and quantitation of very low numbers of hepatitis C virus (HCV) particles in biological samples is an issue of interest in both clinical and analytical fields of HCV research. A sensitive and reproducible assay is described for HCV RNA quantitation using the TaqMan PCR fluorogenic real-time detection system to establish the levels of HCV RNA in chimpanzee plasma. Our TaqMan PCR protocol and synthetic full length HCV RNA template show that the threshold of sensitivity for our TaqMan PCR is two copies per reaction. As few as 10 genome copies per reaction could be quantitated maintaining a linear range. The accuracy of the TaqMan PCR test was comparable to commercial bDNA and Amplicor tests. The RNA standards of the laboratory were tested in parallel with a World Health Organization (WHO) International Standard for HCV RNA obtaining ratios of 2.7 +/- 0.7 RNA copies per HCV international unit (IU). Our method using RNA extracted from chimpanzee samples had an estimated sensitivity of 200 RNA copies/ml of plasma (approximately eight copies/reaction or 74 WHO IU/ml). Serial plasma samples from HCV-infected chimpanzees were analyzed using this methodology to evaluate its applicability, and RNA profiles were observed consistent with the evolution of the pathology in each animal. The present study therefore illustrates the high reproducibility, sensitivity and reliability of our TaqMan methodology, providing a useful method for HCV research to consistently detect and quantify viral RNA throughout a range of concentrations. Crown Copyright (C) 2002 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 17 条
[1]   Reducing the risk of infection from plasma products: specific preventative strategies [J].
Burnouf, T ;
Radosevich, M .
BLOOD REVIEWS, 2000, 14 (02) :94-110
[2]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[3]   HEPATITIS-C VIRAL-RNA IN SERUM OF PATIENTS WITH CHRONIC NON-A, NON-B HEPATITIS - DETECTION BY THE POLYMERASE CHAIN-REACTION USING MULTIPLE PRIMER SETS [J].
CRISTIANO, K ;
DIBISCEGLIE, AM ;
HOOFNAGLE, JH ;
FEINSTONE, SM .
HEPATOLOGY, 1991, 14 (01) :51-55
[4]   Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant [J].
Doglio, A ;
Laffont, C ;
Caroli-Bosc, FX ;
Rochet, P ;
Lefebvre, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1567-1569
[5]   Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus [J].
Hawrami, K ;
Breuer, J .
JOURNAL OF VIROLOGICAL METHODS, 1999, 79 (01) :33-40
[6]   Routine HCVPCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV [J].
Hitzler, WE ;
Runkel, S .
TRANSFUSION, 2001, 41 (03) :333-337
[7]   Performance characteristics of a quantitative, homogeneous TaqMan RT-PCR test for HCV RNA [J].
Kleiber, J ;
Walter, T ;
Haberhausen, G ;
Tsang, S ;
Babiel, R ;
Rosenstraus, M .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2000, 2 (03) :158-166
[8]   Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA [J].
Kolykhalov, AA ;
Agapov, EV ;
Blight, KJ ;
Mihalik, K ;
Feinstone, SM ;
Rice, CM .
SCIENCE, 1997, 277 (5325) :570-574
[9]   AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS [J].
KUO, G ;
CHOO, QL ;
ALTER, HJ ;
GITNICK, GL ;
REDEKER, AG ;
PURCELL, RH ;
MIYAMURA, T ;
DIENSTAG, JL ;
ALTER, MJ ;
STEVENS, CE ;
TEGTMEIER, GE ;
BONINO, F ;
COLOMBO, M ;
LEE, WS ;
KUO, C ;
BERGER, K ;
SHUSTER, JR ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :362-364
[10]   Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus [J].
Major, ME ;
Mihalik, K ;
Fernandez, J ;
Seidman, J ;
Kleiner, D ;
Kolykhalov, AA ;
Rice, CM ;
Feinstone, SM .
JOURNAL OF VIROLOGY, 1999, 73 (04) :3317-3325